PREVALENCE OF FATIGUE AND IMPACT ON QUALITY OF LIFE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: the VITAL study

Abstract Background Fatigue is one of the most prevalent symptoms among cancer patients. Specifically, in metastatic castration-resistant prostate cancer (mCRPC) patients, fatigue is the most common adverse event associated with current treatments. The purpose of this study is to describe the preval...

Full description

Bibliographic Details
Main Authors: A. Rodríguez Antolín, L. Martínez-Piñeiro, M. E. Jiménez Romero, J. B. García Ramos, D. López Bellido, J. Muñoz del Toro, A. García García-Porrero, F. Gómez Veiga
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Urology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12894-019-0527-8